Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
Objective: The primary objective of this work was to confirm the occurrence of rare BCR ABL fusion variant involving the a3 region of the ABL gene in a patient positive for t(9;22) translocation but negative for common major and minor breakpoint cluster regions and the challenges and threats that it...
Saved in:
Main Authors: | Salil Vaniawala, Arpan Acharya, Harsh Parekh, Pratap N. Mukhopadhyaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.3233/ACP-130083 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia
by: Aytan Shirinova
Published: (2024-03-01) -
Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation
by: Stephen E. Langabeer, et al.
Published: (2023-01-01) -
Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 BCR-ABL1 Fusion
by: Mireille Crampe, et al.
Published: (2019-01-01) -
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
by: Alessandro Morotti, et al.
Published: (2015-01-01) -
De Novo Acute Myeloid Leukemia with Combined CBFB-MYH11 and BCR-ABL1 Gene Rearrangements: A Case Report and Review of Literature
by: Venkata Rakesh Sethapati, et al.
Published: (2020-01-01)